Marshelle Smith Warren, MD

Experienced drug developer in oncology, immunology and infectious disease, Dr. Warren has had a focus on viral malignancies, T cell-directed therapies and autoimmunity with prior leadership and clinical development roles at Allovir, Viracta Therapeutics, Atara Biotherapeutics, Ionis, Gilead, Amgen, and AstraZeneca. During her career, Dr. Warren has made significant contributions to approved products in immunology including blockbuster Enbrel® and Accolate®.